ATE491706T1 - Heterocyclische antivirale verbindungen - Google Patents
Heterocyclische antivirale verbindungenInfo
- Publication number
- ATE491706T1 ATE491706T1 AT07704418T AT07704418T ATE491706T1 AT E491706 T1 ATE491706 T1 AT E491706T1 AT 07704418 T AT07704418 T AT 07704418T AT 07704418 T AT07704418 T AT 07704418T AT E491706 T1 ATE491706 T1 AT E491706T1
- Authority
- AT
- Austria
- Prior art keywords
- antiviral compounds
- heterocyclic antiviral
- heterocyclic
- compounds
- hepatitis
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000000840 anti-viral effect Effects 0.000 title 1
- 108700008776 hepatitis C virus NS-5 Proteins 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77441906P | 2006-02-17 | 2006-02-17 | |
| PCT/EP2007/051162 WO2007093541A1 (en) | 2006-02-17 | 2007-02-07 | Heterocyclic antiviral compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE491706T1 true ATE491706T1 (de) | 2011-01-15 |
Family
ID=38115973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07704418T ATE491706T1 (de) | 2006-02-17 | 2007-02-07 | Heterocyclische antivirale verbindungen |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7531534B2 (de) |
| EP (1) | EP1987027B1 (de) |
| JP (1) | JP2009526808A (de) |
| KR (1) | KR20080094834A (de) |
| CN (1) | CN101384587B (de) |
| AT (1) | ATE491706T1 (de) |
| AU (1) | AU2007216564B2 (de) |
| BR (1) | BRPI0708067A2 (de) |
| CA (1) | CA2642483A1 (de) |
| DE (1) | DE602007011213D1 (de) |
| ES (1) | ES2355945T3 (de) |
| IL (1) | IL193113A0 (de) |
| WO (1) | WO2007093541A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7932240B2 (en) * | 2007-08-31 | 2011-04-26 | Idenix Pharmaceuticals, Inc. | Phosphadiazine HCV polymerase inhibitors IV |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040034041A1 (en) | 2000-05-10 | 2004-02-19 | Dashyant Dhanak | Novel anti-infectives |
| AR036081A1 (es) | 2001-06-07 | 2004-08-11 | Smithkline Beecham Corp | Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos |
| AU2002359320A1 (en) * | 2001-10-29 | 2003-05-12 | Smithkline Beecham Corporation | Novel anit-infectives |
| AU2003248566A1 (en) * | 2002-05-24 | 2003-12-12 | Smithkline Beecham Corporation | Novel anti-infectives |
| US20040097492A1 (en) * | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
| PL376823A1 (pl) | 2002-11-01 | 2006-01-09 | Abbott Laboratories | Środki przeciwzakaźne |
| US20040162285A1 (en) * | 2002-11-01 | 2004-08-19 | Pratt John K. | Anti-infective agents |
| US7902203B2 (en) * | 2002-11-01 | 2011-03-08 | Abbott Laboratories, Inc. | Anti-infective agents |
| US20050075331A1 (en) * | 2003-10-06 | 2005-04-07 | Pratt John K. | Anti-infective agents |
| AU2003300957A1 (en) | 2002-12-11 | 2004-06-30 | Smithkline Beecham Corporation | Anti-infectives |
| WO2004058150A2 (en) | 2002-12-17 | 2004-07-15 | Smithkline Beecham Corporation | Anti-infectives |
| ATE437875T1 (de) * | 2004-08-23 | 2009-08-15 | Hoffmann La Roche | Heterozyklische antivirale verbindungen |
-
2007
- 2007-02-07 KR KR1020087022595A patent/KR20080094834A/ko not_active Ceased
- 2007-02-07 JP JP2008554739A patent/JP2009526808A/ja active Pending
- 2007-02-07 AT AT07704418T patent/ATE491706T1/de active
- 2007-02-07 ES ES07704418T patent/ES2355945T3/es active Active
- 2007-02-07 WO PCT/EP2007/051162 patent/WO2007093541A1/en not_active Ceased
- 2007-02-07 AU AU2007216564A patent/AU2007216564B2/en not_active Ceased
- 2007-02-07 BR BRPI0708067-0A patent/BRPI0708067A2/pt not_active IP Right Cessation
- 2007-02-07 EP EP07704418A patent/EP1987027B1/de not_active Not-in-force
- 2007-02-07 CA CA002642483A patent/CA2642483A1/en not_active Abandoned
- 2007-02-07 DE DE602007011213T patent/DE602007011213D1/de active Active
- 2007-02-07 CN CN2007800059164A patent/CN101384587B/zh not_active Expired - Fee Related
- 2007-02-15 US US11/706,777 patent/US7531534B2/en not_active Expired - Fee Related
-
2008
- 2008-07-29 IL IL193113A patent/IL193113A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2642483A1 (en) | 2007-08-23 |
| US7531534B2 (en) | 2009-05-12 |
| BRPI0708067A2 (pt) | 2011-05-17 |
| AU2007216564A1 (en) | 2007-08-23 |
| DE602007011213D1 (de) | 2011-01-27 |
| WO2007093541A1 (en) | 2007-08-23 |
| JP2009526808A (ja) | 2009-07-23 |
| EP1987027B1 (de) | 2010-12-15 |
| KR20080094834A (ko) | 2008-10-24 |
| CN101384587A (zh) | 2009-03-11 |
| IL193113A0 (en) | 2009-02-11 |
| ES2355945T3 (es) | 2011-04-01 |
| US20080095739A1 (en) | 2008-04-24 |
| AU2007216564B2 (en) | 2011-09-01 |
| CN101384587B (zh) | 2011-03-30 |
| EP1987027A1 (de) | 2008-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012003170A (es) | Compuestos heterociclicos antivirales. | |
| MX2010004623A (es) | Compuestos heterociclicos antiviricos. | |
| MX2012008443A (es) | Nucleosidos antiviricos. | |
| TW200745151A (en) | Antiviral nucleosides | |
| WO2009069095A3 (en) | Antiviral nucleoside compounds | |
| MX2009008872A (es) | Compuestos macrociclicos como inhibidores de proteasa ns3 del virus de hepatitis c. | |
| ATE505475T1 (de) | Nukleosidderivate als inhibitoren viraler polymerasen | |
| TW200602064A (en) | Nucleoside derivatives for treating hepatitis C virus infection | |
| EA201000948A1 (ru) | Ингибиторы вирусной полимеразы | |
| MX2009004556A (es) | Inhibidores de la proteasa ns3 del hcv. | |
| TW200745120A (en) | Indolobenzazepine HCV NS5B inhibitors | |
| ATE469155T1 (de) | Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b- hemmer | |
| DK1987038T3 (da) | HCV NS5B-hæmmere | |
| MY157435A (en) | Heterocyclic antiviral compounds | |
| MY152070A (en) | Macrocyclic quinxaline compounds as hcv ns3 protease inhibitors | |
| CO6190510A2 (es) | Inhibidores del virus de la hepatitis c | |
| EA200900676A1 (ru) | Ингибиторы вируса гепатита с | |
| TW200720285A (en) | Nucleoside compounds for treating viral infections | |
| NO20084637L (no) | Cyklopropyl-kondenserte indolobenzaepin HCV NS5B inhibitorer | |
| WO2008051475A3 (en) | Hcv ns3 protease inhibitors | |
| TW200724540A (en) | Heterocyclic antiviral compounds | |
| DK2209789T3 (da) | Cyclopropyl-kondenserede indolobenzazepin HCV NS5B-hæmmere | |
| MX2011012541A (es) | Compuestos heterociclicos antivirales. | |
| MX2012006513A (es) | Compuestos heterociclicos antivirales. | |
| MX2011011112A (es) | Compuestos antivirales heterociclicos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1987027 Country of ref document: EP |